Skip to content
FrontierPicks

Covered

AEYE · AudioEye

Conviction · Low · more likely to lag the S&P 500 over the next three months

Wrong if: a daily close above $16.52

Note written ·

Price against the kill line

18.5% clear of its kill line on the 13 November 2026 close.

How to read this

This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

AEYEAudioEye
$16.52
$13.47
18.5%well clear

Three months against the kill line

AEYE daily closes from 17 August 2026 to 13 November 2026, last $13.47, against its kill line: a daily close above $16.52. 17 August 2026: $8.2618 August 2026: $7.3619 August 2026: $7.0720 August 2026: $7.1421 August 2026: $7.2024 August 2026: $7.3125 August 2026: $7.3726 August 2026: $7.2227 August 2026: $7.1928 August 2026: $7.1631 August 2026: $7.371 September 2026: $7.012 September 2026: $7.203 September 2026: $7.274 September 2026: $7.618 September 2026: $7.979 September 2026: $7.7610 September 2026: $7.5011 September 2026: $7.9314 September 2026: $8.0315 September 2026: $7.3816 September 2026: $7.2117 September 2026: $7.5218 September 2026: $7.3421 September 2026: $6.9222 September 2026: $7.2923 September 2026: $7.1424 September 2026: $7.2025 September 2026: $6.8628 September 2026: $6.7929 September 2026: $6.6330 September 2026: $6.721 October 2026: $6.942 October 2026: $6.925 October 2026: $6.736 October 2026: $6.927 October 2026: $6.958 October 2026: $6.849 October 2026: $6.9312 October 2026: $7.0613 October 2026: $6.9914 October 2026: $6.7815 October 2026: $7.0016 October 2026: $6.6619 October 2026: $6.9620 October 2026: $8.1921 October 2026: $7.8822 October 2026: $8.1023 October 2026: $8.0826 October 2026: $7.4227 October 2026: $10.1428 October 2026: $11.9429 October 2026: $14.1230 October 2026: $13.032 November 2026: $13.353 November 2026: $13.594 November 2026: $12.895 November 2026: $12.066 November 2026: $12.379 November 2026: $12.9610 November 2026: $13.6711 November 2026: $13.7712 November 2026: $14.3013 November 2026: $13.47

Daily closes, to . Red: the kill line, a daily close above $16.52, on record since 11 November 2026. The shares are up 63.1% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close above $16.52, over the $14.68 intraday high of 30 October 2026, which would show the shares leading the S&P 500. A fourth-quarter revenue result above the $11.6 million top of guidance would also show that.

Research onlyNot in the portfolio.

The portfolio's record →

Key figures from the filings · Technology

Quarter to 30 September 2026, filed 26 October 2026; valuation at the 13 November 2026 close

Revenue, latest quarter ($M)
11.0
Revenue, change on a year (%)
+7.2
Gross margin (%)
82.9
Operating margin (%)
11.4
Free cash flow, four quarters ($M)
6.5
Net cash, cash less debt ($M)
−6.9
Enterprise value to sales (×)
4.2
Free-cash-flow yield (%)
3.8
All filed numbers

What AudioEye reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 11.0 +7.2 82.9 11.4
first filed 10.7 +8.7 78.8 −5.6
first filed 10.6 +8.4 78.2 −17.8
first filed 10.5 +7.9 78.9 −7.8
first filed 10.2 +14.6 77.4 −3.1
first filed 9.9 +16.4 77.3 2.5
Income Quarter to 30 September 2026, filed 26 October 2026
Pre-tax income ($M) Not reported
Net income ($M) four quarters: −3.0 1.0
Diluted shares, change on a year (%) against the quarter to 30 September 2025 +4.5
Cash flow Four quarters to 30 September 2026, filed 26 October 2026
Operating cash flow ($M) 6.6
Capital spending ($M) 0.1
Free cash flow ($M) 6.5
Balance sheet At 30 September 2026, filed 26 October 2026
Cash and short-term investments ($M) 9.3
Debt ($M) long-term debt 16.2
Net cash, cash less debt ($M) −6.9
Deferred revenue ($M) +12.9% on a year 8.4
Backlog, orders not yet delivered ($M) Not reported
Receivables ($M) 5.8
Inventory ($M) Not reported
Shareholders' equity ($M) 5.1
Valuation At the 13 November 2026 close, filed figures to 26 October 2026
Market value ($M) 171
Enterprise value, market value plus net debt ($M) 178
Enterprise value to sales (×) 4.2
Enterprise value to operating income (×) Not meaningful
Price to earnings (×) Not meaningful
Price to book value (×) 33.7
Free-cash-flow yield (%) 3.8

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 2.1% of shares outstanding sold short, 5.3 days of average trading to cover, +0.5% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $128K $2.7M
12 monthsfrom $538K $2.7M

The thesis

AudioEye's shares are more likely to lag the S&P 500 than lead it over the next three months. The company is now profitable, but revenue grew 7% in the third quarter, its executive chairman kept selling stock after the post-earnings surge, and the shares have already risen 137.0% in three months; the fourth-quarter report, due around March 2027, settles whether earnings keep climbing.

The shares closed at $13.77 on 11 November 2026, against $5.81 on 13 August 2026. The consensus target of $14.62 from six analysts (four Buy, one Hold, one Sell; The Cerbat Gem, 5 November 2026) sits close to that price. The market has therefore already paid for the margin step-up reported on 26 October 2026.

David Moradi, executive chairman, chief product officer, director and 10% owner, reported two sets of open-market sales through Sero Capital LLC. The first was 177,641 shares from 30 October to 3 November 2026 at an average of $13.50 (Form 4 filed 3 November 2026). The second was 22,359 shares on 4 November 2026 at an average of $12.72 (Form 4 filed 6 November 2026).

The business case rests on margins. Third-quarter revenue rose 7% to $10.96 million, while adjusted EBITDA (earnings before interest, taxes, depreciation and amortisation, excluding items the company adjusts out) rose to $3.89 million from $2.45 million (company release, 26 October 2026). Management guides 2026 adjusted EBITDA to $13.4–13.6 million.

Bullish and bearish views on AudioEye, Inc.

The bull case on AudioEye, Inc. (AEYE), in brief: GAAP profit arrived in the third quarter. The bear case: the executive chairman keeps selling.

Bull case

  • GAAP profit arrived in the third quarter. Net income was $0.99 million, or $0.08 per diluted share, against a $0.55 million loss a year earlier (company release, 26 October 2026). Adjusted gross margin rose to 88% from 83%.
  • Earnings guidance beat consensus. The 2026 adjusted earnings-per-share guide of at least $1.04 compares with a $0.98 consensus, and the fourth-quarter guide of $0.32–$0.33 compares with $0.30 (Benzinga, 26 October 2026).
  • Recurring revenue keeps growing. Annual recurring revenue (ARR) reached $43.3 million on 30 September 2026, up 12% year over year (company release). The Form 10-Q counts about 130,000 customers on that date, up 6% from about 123,000.
  • Cash generation improved. Operating cash flow for the first nine months of 2026 was $4.04 million, against $2.22 million a year earlier (Form 10-Q). Cash rose to $9.33 million on 30 September 2026 from $5.29 million on 31 December 2025.
  • The lender loosened buyback terms. A loan modification dated 26 October 2026 removed the dollar cap on repurchases under the term loan (Form 10-Q). The board authorised up to $15 million of repurchases through 18 October 2027, announced on 20 October 2026.
  • A director keeps buying. James Hawkins bought 3,000 shares at $12.34 on 29 October 2026, 4,000 at $13.15 on 30 October 2026 and 3,000 at $12.77 on 4 November 2026 (SEC Form 4 filings).

Bear case

  • The executive chairman keeps selling. Moradi's sales ran from the $13.33–$14.16 range on 30 October 2026 and 3 November 2026 to a $12.72 average on 4 November 2026 (Form 4 filings). The 3 November 2026 form shows 1,771,966 shares held through Sero and 797,595 held directly after those sales, and it does not mark them as made under a Rule 10b5-1 pre-arranged plan.
  • Sales growth is single-digit. Third-quarter revenue grew 7%. The 2026 sales guide narrowed to $43.6–$43.8 million from $43.5–$44.0 million, against a $43.619 million consensus, and the fourth-quarter sales guide is $11.4–$11.6 million (Benzinga, 26 October 2026).
  • The buyback is authorised, not yet used. The company bought no shares under the new programme through 26 October 2026 and none under the prior one in the third quarter (Form 10-Q). Repurchases require no event of default and at least $5.0 million of liquidity afterward, and the $15 million authorisation exceeds the $9.33 million of cash on 30 September 2026.
  • Debt exceeds cash. Term loan principal was $16.6 million on 30 September 2026, and stockholders' equity was $5.08 million. Covenants cap funded debt at 2.50 times adjusted EBITDA through 30 June 2027, then 2.00 times (Form 10-Q).
  • Revenue is concentrated. Two customers accounted for 11% and 12% of third-quarter revenue (Form 10-Q).
  • Litigation costs still weigh on GAAP results. Litigation expense was $3.40 million for the first nine months of 2026, against $1.94 million a year earlier, and the nine-month GAAP net loss was $1.99 million (company release, 26 October 2026).

Price setup

The shares closed at $12.89 on 4 November 2026, $12.06 on 5 November 2026, $12.37 on 6 November 2026, $12.96 on 9 November 2026, $13.67 on 10 November 2026 and $13.77 on 11 November 2026. The 52-week intraday high is $14.68, set on 30 October 2026, and the last close is 6.2% below it. The 52-week closing low is $5.40, on 24 March 2026.

The 50-day average of adjusted closes is $8.59 and the 200-day average is $7.27, both far under the last close. Benzinga reported the shares up 33.96% to $9.94 in the intraday session on 27 October 2026, the first session after the third-quarter report. The shares have since traded above that level on every close listed above.

The 52-week intraday high of $14.68 is the nearest level the case turns on. A close beyond it would extend the post-earnings move; a close back toward the 5 November 2026 low of $12.06 would show the buying fading.

With 12,684,577 shares outstanding on 26 October 2026 (Form 10-Q), modest volume can move the price sharply. The company announced on 12 November 2026 that it will take part in investor conferences in November.

Catalysts ahead

  • ~5 March 2027 (est.): Q4 and full-year 2026 report. Tests whether adjusted EBITDA reaches the $13.4–13.6 million guide, Q4 revenue reaches the $11.4–11.6 million guide and ARR growth holds near 12%, and shows whether the company used the $15 million buyback.

What would change the view

A daily close above $16.52, over the $14.68 intraday high of 30 October 2026, which would show the shares leading the S&P 500. A fourth-quarter revenue result above the $11.6 million top of guidance would also show that.

What it trades with

AudioEye's move came from its own results and its buyback news, so the read depends little on software peers. The 27 October 2026 surge followed the company's own third-quarter report, with no sector news behind it. This view would be wrong if AudioEye's largest daily moves began tracking a software peer group on days with no company news.

The evidence, claim by claim (8)
  1. David Moradi reported selling 22,359 shares at an average of $12.72 on 4 November 2026, after 177,641 shares sold from 30 October to 3 November 2026 at an average of $13.50. SEC Form 4 filings for AudioEye, filed 3 November 2026 and 6 November 2026 · as of
  2. Q3 2026 revenue was $10.96 million, up 7% year over year from $10.23 million. AudioEye Q3 2026 earnings release · as of
  3. Q3 adjusted EBITDA was $3.89 million (35% margin), against $2.45 million (24%) a year earlier; GAAP net income was $0.99 million. AudioEye Q3 2026 earnings release · as of
  4. ARR was $43.3 million, up 12% year over year and up from $42.3 million at 30 June 2026. AudioEye Q3 2026 earnings release · as of
  5. 2026 guidance: adjusted EBITDA of $13.4–13.6 million, adjusted EPS of at least $1.04 and revenue of $43.6–43.8 million; Q4 sales guide $11.4–11.6 million. AudioEye Q3 2026 earnings release; Benzinga · as of
  6. Cash was $9.33 million against $16.6 million of term loan principal; nine-month operating cash flow was $4.04 million, up from $2.22 million a year earlier. AudioEye Q3 2026 Form 10-Q · as of
  7. No shares had been repurchased under the new $15 million programme through 26 October 2026, and none under the prior programme in the third quarter. AudioEye Q3 2026 Form 10-Q · as of
  8. Consensus target is $14.62 from six analysts: four Buy, one Hold, one Sell. The Cerbat Gem, 5 November 2026 · as of

Sources

Related · shared themes

See also · stocks to watch

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X